MOSCOW--(Marketwired - Apr 16, 2013) - Cromos Pharma, an international full service contract research organization (CRO), announced today that it opened an office in the Republic of Georgiа.
"Georgia is a very important location for Cromos Pharma," noted Dr. Vladimir Bogin, Chief Executive Officer of Cromos Pharma. "Some of the unique qualities of Georgiа are its very streamlined and time-efficient regulatory approval process, good quality of medical care and historically high recruitment and retention rates."
"We were very lucky to have been able to attract a very experienced professional team to our new office in Tbilisi. Its unique expertise and established relationships with key opinion leaders and investigators guarantees that Cromos Pharma will provide both high rate of recruitment and competitive, quality services in yet another country," said Andrey Tarakanov, MD, Cromos Pharma's Managing Director.
With addition of Georgiа, Cromos Pharma plans to compete for an even larger number of multi-center, international clinical trials. Employing its cloud-based software system, the company has been able to achieve a seamless integration of the Tbilisi office, which is now part of Cromos Pharma's successful and cost-efficient virtual workplace model.
About Cromos Pharma, LLC
Cromos Pharma, LLC is a contract research organization (CRO) with operations in Russia, Ukraine and Eastern Europe and a business development office in the United States. The company provides a full spectrum of trial-related services which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos Pharma, LLC is a privately owned company.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.